Human nasal epithelial organoids for therapeutic development in cystic fibrosis

Academic Article

Abstract

  • © 2020 by the authors. Licensee MDPI, Basel, Switzerland. We describe a human nasal epithelial (HNE) organoid model derived directly from patient samples that is well-differentiated and recapitulates the airway epithelium, including the expression of cilia, mucins, tight junctions, the cystic fibrosis transmembrane conductance regulator (CFTR), and ionocytes. This model requires few cells compared to airway epithelial monolayer cultures, with multiple outcome measurements depending on the application. A novel feature of the model is the predictive capacity of lumen formation, a marker of baseline CFTR function that correlates with short-circuit current activation of CFTR in monolayers and discriminates the cystic fibrosis (CF) phenotype from non-CF. Our HNE organoid model is amenable to automated measurements of forskolin-induced swelling (FIS), which distinguishes levels of CFTR activity. While the apical side is not easily accessible, RNA-and DNA-based therapies intended for systemic administration could be evaluated in vitro, or it could be used as an ex vivo biomarker of successful repair of a mutant gene. In conclusion, this highly differentiated airway epithelial model could serve as a surrogate biomarker to assess correction of the mutant gene in CF or other diseases, recapitulating the phenotypic and genotypic diversity of the population.
  • Published In

  • Genes  Journal
  • Digital Object Identifier (doi)

    Author List

  • Liu Z; Anderson JD; Deng L; Mackay S; Bailey J; Kersh L; Rowe SM; Guimbellot JS
  • Start Page

  • 1
  • End Page

  • 17
  • Volume

  • 11
  • Issue

  • 6